MERTK and neoplasm: Despite valiant efforts by a graduate student, Yemsratch Akalu, to ablate Mertk in dendritic cells, myeloid cells, and endothelial cells, the proposed anti-tumor immunity observed in Mertktm1Gkm/tm1Gkm mice was not recapitulated.